CYMODIQ Trademark
CYMODIQ is a USPTO trademark filed by Pfizer Inc.. Status: Pending.
Trademark Facts
| Mark | CYMODIQ |
|---|---|
| Serial Number | 97853485 |
| Status | Pending |
| Filing Date | 2023-03-23 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Pfizer Inc. |
| Attorney of Record | Yana Gorbach |
| Prosecution Events | 35 |
| Latest Event | EXRA on 2026-02-03 |
Goods & Services
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use